Deutsch English Français

Contact

EP1621219

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1621219

EP1621219 - Intraocular implants for preventing transplant rejection in the eye [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 27.07.2007 Database last updated on 25.09.2024
Most recent event Tooltip	01.08.2008	Change - applicant	published on 03.09.2008 [2008/36]
Applicant(s)	For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, CA 92612 / US
	[N/P]
Former [2008/36]	For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine CA 92612 / US
Former [2006/05]	For all designated states ALLERGAN, INC. 2525 Dupont Drive Irvine, California 92623-9534 / US
Inventor(s)	01 / Wong, Vernon, G. 180 Sand Hill Circle Menlo Park CA 94025 / US
	[2006/05]
Representative(s)	Sexton, Jane Helen J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB
	[N/P]
Former [2006/05]	Sexton, Jane Helen J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ / GB
Application number, filing date	05021226.5	28.11.2001
	[2006/05]
Priority number, date	US20000250023P	29.11.2000 Original published format: US 250023 P
	US20010298253P	12.06.2001 Original published format: US 298253 P
	[2006/05]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP1621219
	Date:	01.02.2006
	Language:	EN
	[2006/05]
	Type:	A3 Search report
	No.:	EP1621219
	Date:	22.03.2006
	[2006/12]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	06.02.2006
Classification	IPC:	A61L27/54, A61K9/00, A61K31/573, A61P37/06, A61P27/02, A61L31/16	[2006/05]
	CPC:	A61K9/0051 (EP); A61P27/02 (EP); A61P37/06 (EP)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2006/05]
Title	German:	Intraokulare Implantate zur Verhinderung von Transplantatabstossung im Auge	[2006/05]
	English:	Intraocular implants for preventing transplant rejection in the eye	[2006/05]
	French:	Implants intra-oculaires pour la prévention du rejet de greffe de l'oeil	[2006/05]
Examination procedure	06.07.2006	Examination requested [2006/33]
	24.08.2006	Despatch of a communication from the examining division (Time limit: M06)
	06.03.2007	Application deemed to be withdrawn, date of legal effect [2007/35]
	10.04.2007	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/35]
Parent application(s) Tooltip	EP01986027.9 / EP1339438
Fees paid	Renewal fee
	29.09.2005	Renewal fee patent year 03
	29.09.2005	Renewal fee patent year 04
	29.09.2005	Renewal fee patent year 05
	27.11.2006	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]US4863457 (LEE DAVID A [US]) [X] 1-26 * column A * * column 4, line 28 - line 39 * * column 6, line 58 - line 61 *;
		[X]EP0430539 (VISIONEX INC [US]) [X] 1-26 * abstract * * page 4, line 16 - line 18 *;
		[X]EP0488401 (SENJU PHARMA CO [JP]) [X] 1-26 * abstract *;
		[X]WO9638174 (OCULEX PHARM INC [US], et al) [X] 1-26 * page 2, line 15 - line 20 * * page 4, line 16 - page 5, line 21 *;
		[X]WO0002564 (UNIV SYDNEY [AU], et al) [X] 1-26 * abstract * * page 4, line 20 - line 27; claim 23 *;
		[X]WO0037056 (OCULEX PHARM INC [US], et al) [X] 1-26 * page 3, line 16 - line 22; examples 1-7 * * page 6, line 23 - page 7, line 30 *;
		[X] - APEL A ET AL, "A SUBCONJUNCTIVAL DEGRADABLE IMPLANT FOR CYCLOSPORINE DELIVERY IN CORNEAL TRANSPLANT THERAPY", CURRENT EYE RESEARCH, IRL PRESS, OXFORD, GB, (199508), vol. 14, no. 8, ISSN 0271-3683, pages 659 - 667, XP001083691 [X] 1-26 * abstract * * "Polymer devices" on page 660 final para. of the discussion *
		[X] - TAN D T H ET AL, "RANDOMIZED CLINICAL TRIAL OF A NEW DEXAMETHASONE DELIVERY SYSTEM (SURODEX) FOR TREATMENT OF POST-CATARACT SURGERY INFLAMMATION", OPHTHALMOLOGY, J. B. LIPPINCOTT CO., PHILADELPHIA, PA, US, (199902), vol. 106, no. 2, ISSN 0161-6420, pages 223 - 231, XP001083687 [X] 1-26 * page 223, column 1, line 1 - page 224, column 1, line 19 * DOI: http://dx.doi.org/10.1016/S0161-6420(99)90060-X
		[X] - MORITA Y ET AL, "INTRAVITREOUS DELIVERY OF DEXAMETHASONE SODIUM M-SOLFOBENZOATE FROM POLY(DL-LACTIC ACID) IMPLANTS", BIOLOGICAL & PHARMACEUTICAL BULLETIN (OF JAPAN), PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, (199802), vol. 21, no. 2, ISSN 0918-6158, pages 188 - 190, XP001084085 [X] 1-26 * abstract * * "preparation of ocular implants" on page 188 *
		[X] - GOULD L ET AL, "FIFTY:FIFTY POLY (DL GLYCOLIC ACID-LACTIC ACID) COPOLYMER AS A DRUG DELIVERY SYSTEM FOR 5-FLUOROURACIL: A HISTOPATHOLOGICAL EVALUATION", CANADIAN JOURNAL OF OPHTHALMOLOGY, (199408), vol. 29, no. 4, ISSN 0008-4182, pages 168 - 171, XP001083692 [X] 1-26 * abstract * * "methods" on page 169 *
		[X] - DAVIS P A ET AL, "INTRAOCULAR IMPLANT FOR CONTROLLED 5-FLUOROURACIL RELEASE", PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE BIOACTIVE MATERIALS, (1992), vol. 19, ISSN 1022-0178, pages 339 - 340, XP001084532 [X] 1-26 * Introduction, Experimental Methods and Conclusions *
		[X] - CHENG C-K ET AL, "Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis", INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE 1995 UNITED STATES, (1995), vol. 36, no. 2, ISSN 0146-0404, pages 442 - 453, XP009045224 [X] 1-26 * abstract * * page 443, column 1, line 29 - line 42 *
		[X] - CHANG DAVID F ET AL, "Phase II results of an intraocular steroid delivery system for cataract surgery", OPHTHALMOLOGY, (199906), vol. 106, no. 6, ISSN 0161-6420, pages 1172 - 1177, XP001205585 [X] 1-26 * abstract * * page 1172, column 2, line 15 - page 1173, column 1, line 6 *
		[X] - ZHOU T ET AL, "Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy", JOURNAL OF CONTROLLED RELEASE, ELSEVIER SCIENCE PUBLISHERS B.V. AMSTERDAM, NL, (19981113), vol. 55, no. 2-3, ISSN 0168-3659, pages 281 - 295, XP004143523 [X] 1-26 * abstract * DOI: http://dx.doi.org/10.1016/S0168-3659(98)00061-3
		[X] - KUNOU NORIYUKI ET AL, "Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate", J BIOMED MATER RES; JOURNAL OF BIOMEDICAL MATERIALS RESEARCH 2000 JOHN WILEY & SONS INC, NEW YORK, NY, USA, (2000), vol. 51, no. 4, pages 635 - 641, XP001205588 [X] 1-26 * abstract * DOI: http://dx.doi.org/10.1002/1097-4636(20000915)51:4<635::AID-JBM11>3.0.CO;2-O
		[X] - MORITA Y ET AL, "POLYMER BLEND IMPLANT FOR OCULAR DELIVERY OF FLUOROMETHOLONE", BIOLOGICAL & PHARMACEUTICAL BULLETIN (OF JAPAN), PHARMACEUTICAL SOCIETY OF JAPAN, JP, (1998), vol. 21, no. 1, ISSN 0918-6158, pages 72 - 75, XP000738276 [X] 1-26 * abstract *
		[X] - ROBIN JEFFREY B. ET AL, "The histopathology of corneal neovascularization. Inhibitor effects", CA, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, (1985), Database accession no. 1985:219200, URL: STN, XP002285068 [X] 1-26 * abstract *
		[X] - TABA K E ET AL, "Intravitreal sustained release fluocinolone implant inhibits experimental choroidal neovascularization", IOVS, & ANNUAL MEETING OF THE ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY; FORT LAUDERDALE, FLORIDA, USA; MAY 9-14, 1999, (19990315), vol. 40, no. 4, page S172, XP009045225 [X] 1-26 * abstract *
		[X] - BINGAMAN D P ET AL, "Inhibition of preretinal neovascularization in pigs by intravitreal triamcinolone acetonide", INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE, & ANNUAL MEETING OF THE INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE; FORT LAUDERDALE, FLORIDA, USA; MAY 14-19, 1995, (1995), vol. 36, no. 4, ISSN 0146-0404, page S401, XP009045218 [X] 1-26 * abstract *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p